ATE457649T1 - Triglyceridfett - Google Patents

Triglyceridfett

Info

Publication number
ATE457649T1
ATE457649T1 AT03712001T AT03712001T ATE457649T1 AT E457649 T1 ATE457649 T1 AT E457649T1 AT 03712001 T AT03712001 T AT 03712001T AT 03712001 T AT03712001 T AT 03712001T AT E457649 T1 ATE457649 T1 AT E457649T1
Authority
AT
Austria
Prior art keywords
fat
triglycerides
acid residues
fatty acid
carbon atoms
Prior art date
Application number
AT03712001T
Other languages
English (en)
Inventor
Eckhard Floeter
Original Assignee
Unilever Nv
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Unilever Nv filed Critical Unilever Nv
Application granted granted Critical
Publication of ATE457649T1 publication Critical patent/ATE457649T1/de

Links

Classifications

    • A—HUMAN NECESSITIES
    • A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
    • A23D—EDIBLE OILS OR FATS, e.g. MARGARINES, SHORTENINGS, COOKING OILS
    • A23D7/00—Edible oil or fat compositions containing an aqueous phase, e.g. margarines
    • A23D7/001—Spread compositions
    • A—HUMAN NECESSITIES
    • A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
    • A23D—EDIBLE OILS OR FATS, e.g. MARGARINES, SHORTENINGS, COOKING OILS
    • A23D9/00—Other edible oils or fats, e.g. shortenings, cooking oils
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
    • A61K47/50—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient the non-active ingredient being chemically bound to the active ingredient, e.g. polymer-drug conjugates
    • A61K47/51—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient the non-active ingredient being chemically bound to the active ingredient, e.g. polymer-drug conjugates the non-active ingredient being a modifying agent
    • A61K47/54—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient the non-active ingredient being chemically bound to the active ingredient, e.g. polymer-drug conjugates the non-active ingredient being a modifying agent the modifying agent being an organic compound
    • A61K47/555—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient the non-active ingredient being chemically bound to the active ingredient, e.g. polymer-drug conjugates the non-active ingredient being a modifying agent the modifying agent being an organic compound pre-targeting systems involving an organic compound, other than a peptide, protein or antibody, for targeting specific cells
    • A61K47/557—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient the non-active ingredient being chemically bound to the active ingredient, e.g. polymer-drug conjugates the non-active ingredient being a modifying agent the modifying agent being an organic compound pre-targeting systems involving an organic compound, other than a peptide, protein or antibody, for targeting specific cells the modifying agent being biotin
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
    • A61K47/50—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient the non-active ingredient being chemically bound to the active ingredient, e.g. polymer-drug conjugates
    • A61K47/51—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient the non-active ingredient being chemically bound to the active ingredient, e.g. polymer-drug conjugates the non-active ingredient being a modifying agent
    • A61K47/62—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient the non-active ingredient being chemically bound to the active ingredient, e.g. polymer-drug conjugates the non-active ingredient being a modifying agent the modifying agent being a protein, peptide or polyamino acid
    • A61K47/66—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient the non-active ingredient being chemically bound to the active ingredient, e.g. polymer-drug conjugates the non-active ingredient being a modifying agent the modifying agent being a protein, peptide or polyamino acid the modifying agent being a pre-targeting system involving a peptide or protein for targeting specific cells
    • A61K47/665—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient the non-active ingredient being chemically bound to the active ingredient, e.g. polymer-drug conjugates the non-active ingredient being a modifying agent the modifying agent being a protein, peptide or polyamino acid the modifying agent being a pre-targeting system involving a peptide or protein for targeting specific cells the pre-targeting system, clearing therapy or rescue therapy involving biotin-(strept) avidin systems
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
    • A61K47/50—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient the non-active ingredient being chemically bound to the active ingredient, e.g. polymer-drug conjugates
    • A61K47/51—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient the non-active ingredient being chemically bound to the active ingredient, e.g. polymer-drug conjugates the non-active ingredient being a modifying agent
    • A61K47/68—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient the non-active ingredient being chemically bound to the active ingredient, e.g. polymer-drug conjugates the non-active ingredient being a modifying agent the modifying agent being an antibody, an immunoglobulin or a fragment thereof, e.g. an Fc-fragment
    • A61K47/6891—Pre-targeting systems involving an antibody for targeting specific cells
    • A61K47/6897—Pre-targeting systems with two or three steps using antibody conjugates; Ligand-antiligand therapies
    • A61K47/6898—Pre-targeting systems with two or three steps using antibody conjugates; Ligand-antiligand therapies using avidin- or biotin-conjugated antibodies
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
    • A61K47/50—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient the non-active ingredient being chemically bound to the active ingredient, e.g. polymer-drug conjugates
    • A61K47/69—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient the non-active ingredient being chemically bound to the active ingredient, e.g. polymer-drug conjugates the conjugate being characterised by physical or galenical forms, e.g. emulsion, particle, inclusion complex, stent or kit
    • A61K47/6901—Conjugates being cells, cell fragments, viruses, ghosts, red blood cells or viral vectors
    • B—PERFORMING OPERATIONS; TRANSPORTING
    • B82—NANOTECHNOLOGY
    • B82Y—SPECIFIC USES OR APPLICATIONS OF NANOSTRUCTURES; MEASUREMENT OR ANALYSIS OF NANOSTRUCTURES; MANUFACTURE OR TREATMENT OF NANOSTRUCTURES
    • B82Y5/00—Nanobiotechnology or nanomedicine, e.g. protein engineering or drug delivery
    • C—CHEMISTRY; METALLURGY
    • C11—ANIMAL OR VEGETABLE OILS, FATS, FATTY SUBSTANCES OR WAXES; FATTY ACIDS THEREFROM; DETERGENTS; CANDLES
    • C11C—FATTY ACIDS FROM FATS, OILS OR WAXES; CANDLES; FATS, OILS OR FATTY ACIDS BY CHEMICAL MODIFICATION OF FATS, OILS, OR FATTY ACIDS OBTAINED THEREFROM
    • C11C3/00—Fats, oils, or fatty acids by chemical modification of fats, oils, or fatty acids obtained therefrom
    • C11C3/04—Fats, oils, or fatty acids by chemical modification of fats, oils, or fatty acids obtained therefrom by esterification of fats or fatty oils
    • C11C3/10—Ester interchange
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N15/00—Mutation or genetic engineering; DNA or RNA concerning genetic engineering, vectors, e.g. plasmids, or their isolation, preparation or purification; Use of hosts therefor
    • C12N15/09—Recombinant DNA-technology
    • C12N15/87—Introduction of foreign genetic material using processes not otherwise provided for, e.g. co-transformation
    • C12N15/873—Techniques for producing new embryos, e.g. nuclear transfer, manipulation of totipotent cells or production of chimeric embryos
    • C12N15/877—Techniques for producing new mammalian cloned embryos
    • C12N15/8775—Murine embryos
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N5/00—Undifferentiated human, animal or plant cells, e.g. cell lines; Tissues; Cultivation or maintenance thereof; Culture media therefor
    • C12N5/0006—Modification of the membrane of cells, e.g. cell decoration
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N5/00—Undifferentiated human, animal or plant cells, e.g. cell lines; Tissues; Cultivation or maintenance thereof; Culture media therefor
    • C12N5/06—Animal cells or tissues; Human cells or tissues
    • C12N5/0602—Vertebrate cells
    • C12N5/0603—Embryonic cells ; Embryoid bodies
    • C12N5/0604—Whole embryos; Culture medium therefor

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • Chemical & Material Sciences (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Genetics & Genomics (AREA)
  • General Health & Medical Sciences (AREA)
  • Wood Science & Technology (AREA)
  • Biomedical Technology (AREA)
  • Organic Chemistry (AREA)
  • Biotechnology (AREA)
  • Zoology (AREA)
  • General Engineering & Computer Science (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Medicinal Chemistry (AREA)
  • Cell Biology (AREA)
  • Molecular Biology (AREA)
  • Veterinary Medicine (AREA)
  • Public Health (AREA)
  • Animal Behavior & Ethology (AREA)
  • Epidemiology (AREA)
  • Developmental Biology & Embryology (AREA)
  • Biochemistry (AREA)
  • Microbiology (AREA)
  • Oil, Petroleum & Natural Gas (AREA)
  • Immunology (AREA)
  • Food Science & Technology (AREA)
  • Biophysics (AREA)
  • Polymers & Plastics (AREA)
  • Gynecology & Obstetrics (AREA)
  • Reproductive Health (AREA)
  • Nanotechnology (AREA)
  • Medical Informatics (AREA)
  • Plant Pathology (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Physics & Mathematics (AREA)
  • Crystallography & Structural Chemistry (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Hematology (AREA)
AT03712001T 2002-04-09 2003-03-10 Triglyceridfett ATE457649T1 (de)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
EP02076376 2002-04-09
PCT/EP2003/002625 WO2003084337A1 (en) 2002-04-09 2003-03-10 Triglyceride fat

Publications (1)

Publication Number Publication Date
ATE457649T1 true ATE457649T1 (de) 2010-03-15

Family

ID=28685931

Family Applications (1)

Application Number Title Priority Date Filing Date
AT03712001T ATE457649T1 (de) 2002-04-09 2003-03-10 Triglyceridfett

Country Status (12)

Country Link
US (1) US7524524B2 (de)
EP (1) EP1492410B1 (de)
AT (1) ATE457649T1 (de)
AU (1) AU2003218752B2 (de)
BR (1) BR0308747B1 (de)
CA (1) CA2481700C (de)
DE (1) DE60331298D1 (de)
MX (1) MXPA04009732A (de)
PL (1) PL205287B1 (de)
RU (1) RU2307517C2 (de)
WO (1) WO2003084337A1 (de)
ZA (1) ZA200407149B (de)

Families Citing this family (21)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US6388113B1 (en) 1999-06-04 2002-05-14 Consejo Superior De Investigaciones Cientificas ( Csic) High oleic/high stearic sunflower oils
JP2005535349A (ja) * 2002-08-12 2005-11-24 ユニリーバー・ナームローゼ・ベンノートシヤープ トリグリセリド脂肪
ZA200600076B (en) 2003-07-17 2007-03-28 Unilever Plc Process for the preparation of an edible dispersion comprising oil and structuring agent
GB0409156D0 (en) * 2004-04-24 2004-05-26 Haye Pierre A procedure to manufacture a texturized, thermo-resistant and thermo-irreversible gel composed of vegetable and/or animal fats and the product made with this
DK1841327T3 (da) 2005-01-28 2011-03-14 Unilever Nv Spiselige dispersioner indeholdende olie og strukturmiddel
EP1885192B8 (de) 2005-02-17 2015-05-13 Unilever N.V. Fettgranulat
CA2620716C (en) * 2005-09-26 2013-07-23 Unilever Plc Non-hydrogenated hardstock fat
US8431177B2 (en) * 2007-08-02 2013-04-30 Bunge Oils, Inc. Shortenings and methods of making and using thereof
ATE553655T1 (de) * 2008-01-10 2012-05-15 Team Foods Colombia Sa Festes, trans-fettsäurefreies fettprodukt mit niedrigem gehalt an gesättigten fetten
CA2727090C (en) * 2008-06-11 2017-06-06 General Mills Marketing, Inc. Hydrated fat piece compositions and dough articles made therefrom
HUE033526T2 (en) 2008-12-19 2017-12-28 Unilever Bcs Europe Bv Edible fat powders
MX2011006370A (es) * 2008-12-19 2011-06-24 Unilever Nv Grasas en polvo comestibles.
EP2584907B1 (de) 2010-06-22 2014-04-23 Unilever NV Essbare fettpulver
MX342040B (es) 2010-12-17 2016-09-12 Unilever Nv Emulsion de agua en aceite comestible.
US20130266715A1 (en) 2010-12-17 2013-10-10 René Joachim Buter Process of compacting a microporous fat powder and compacted fat powder so obtained
CA2835102C (en) 2011-05-09 2019-08-06 General Mills, Inc. Fat compositions and related methods, including shortening particles and shortening compositions without added non-interesterified hardstock fat, and related products
KR101831924B1 (ko) * 2011-05-17 2018-02-26 닛신 오일리오그룹 가부시키가이샤 노 템퍼링형 하드 버터로서 사용가능한 유지 조성물
WO2013162802A1 (en) 2012-04-27 2013-10-31 General Mills, Inc. Fat particle compositions containing salt, dough and baked dough articles made therefrom, and related methods
EP2692238A1 (de) * 2012-08-03 2014-02-05 Bunge Növényolajipari Zártköruen Muködo Részvénytársasag Neue Fettmischzusammensetzung
CA2979694C (en) 2015-03-18 2022-11-15 Cargill, Incorporated Low-fat water-in-oil emulsion
CN111378534B (zh) * 2018-12-27 2022-11-25 丰益(上海)生物技术研发中心有限公司 结构酯组合物及其制备方法

Family Cites Families (8)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
GB1107206A (en) 1964-12-28 1968-03-27 Nat Biscuit Co Hard butter and chocolate coating composition containing same
EP0089082B1 (de) 1982-03-12 1985-07-24 Unilever N.V. Margarinefettzusammensetzung und Verfahren zur Herstellung einer solchen Fettzusammensetzung
GB8432058D0 (en) * 1984-12-19 1985-01-30 Unilever Plc Edible fat
DE69103845T2 (de) 1990-08-02 1995-02-02 Unilever Nv Verbesserung essbarer Fette.
ATE121271T1 (de) * 1991-07-03 1995-05-15 Unilever Nv Verbesserte schokolade-zusammensetzung.
US5470598A (en) * 1994-03-23 1995-11-28 The Procter & Gamble Company Beta-prime stable low-saturate, low trans, all purpose shortening
US6238926B1 (en) * 1997-09-17 2001-05-29 Cargilll, Incorporated Partial interesterification of triacylglycerols
GB2350618A (en) 1999-06-01 2000-12-06 Danisco Shortening systems comprising a non-hydrogenated vegetable oil and either a stearine fraction or a saturated fatty acid diglyceride

Also Published As

Publication number Publication date
CA2481700C (en) 2012-10-09
PL371725A1 (en) 2005-06-27
CA2481700A1 (en) 2003-10-16
RU2307517C2 (ru) 2007-10-10
PL205287B1 (pl) 2010-03-31
EP1492410B1 (de) 2010-02-17
EP1492410A1 (de) 2005-01-05
US20050220965A1 (en) 2005-10-06
MXPA04009732A (es) 2005-01-11
WO2003084337A1 (en) 2003-10-16
US7524524B2 (en) 2009-04-28
RU2004132825A (ru) 2005-06-10
AU2003218752A1 (en) 2003-10-20
AU2003218752B2 (en) 2006-12-07
DE60331298D1 (de) 2010-04-01
ZA200407149B (en) 2006-02-22
BR0308747B1 (pt) 2013-12-17
BR0308747A (pt) 2005-01-11

Similar Documents

Publication Publication Date Title
DE60331298D1 (de) Triglyceridfett
MY178510A (en) Plastic fat composition
DK1290119T3 (da) Fremstilling af en blanding af triglycerider
DK1682226T3 (da) Lipidpræparat til forbedring af mineralabsorption
BRPI0517098A (pt) composições de óleo de sementes
BRPI0705244A (pt) composição oleosa de ácido linolênico conjugado
CN100526445C (zh) 含有长链高度不饱和脂肪酸的抗氧脂肪或油组合物
BRPI0416403A (pt) composição de óleo enriquecida em diglicerìdeo com ácido linoléico conjugado
PL372554A1 (en) Triglyceride fat
AR078195A1 (es) Composicion antitranspirante y desodorante
TW200617173A (en) Process for production of microbial fat/oil containing discretional amount of diacylglycerol and said fat/oil
HUP0402214A2 (hu) Önthető zsírdiszperziók
WO2007078311A3 (en) Non-hydrogenated vegetable oil based margarine
DK0455278T3 (da) Spiselige fedtstoffer
EA200201217A1 (ru) Состав для уменьшения гидравлического сопротивления
BRPI0519634A2 (pt) mÉtodo para aumentar o némero de cetano de uma composiÇço de combustÍvel diesel, e, uso de um faae em uma composiÇço de combustÍvel diesel
EP1965652A4 (de) Verkürzung auf basis nicht-hydrogenierten pflanzenöls mithilfe einer erhöhten diglycerin-emulgatoren-zusammensetzung
MY134678A (en) A process for obtaining an oil composition and the oil composition obtained therefrom
BR0202991A (pt) Composição de ésteres de esterol-ácido graxo e alimentos contendo a mesma
ATE138531T1 (de) Triglyceride-zusammensetzungen gegen fettbleichen
WO2004108871A3 (fr) Compositions liquides a base d'huile de colza oleique modifiee, utiles a titre de liquides isolants et caloporteurs, et dispositifs electriques les contenant
BR9913554A (pt) Composição de gordura plástica com caloria reduzida
CA2376104A1 (en) Water-in-oil type emulsified fat and/or oil composition
ATE183364T1 (de) Stabiles, niedrig gesaettigtes allzweck- backfett mit beta-prim-kristallstruktur und mit einem niedrigen transgehalt
DE602005016591D1 (de) Interessante nährstoff- und organoleptische eigens

Legal Events

Date Code Title Description
RER Ceased as to paragraph 5 lit. 3 law introducing patent treaties